Cargando…

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme

Glioblastoma Multiforme (GBM) is the most common malignant primary brain tumor. Despite aggressive multimodality treatment it remains one of the most challenging and intractable cancers (1]. While current standard of care treatment for GBM is maximal safe surgical resection, systemic chemotherapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin, Christopher, Lunking, Emma S., de la Fuente, Macarena, Ayad, Nagi G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243054/ https://www.ncbi.nlm.nih.gov/pubmed/30483476 http://dx.doi.org/10.3389/fonc.2018.00521

Ejemplares similares

Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
por: Schuessler, Andrea, et al.
Publicado: (2014)

Epigenetic pathways and glioblastoma treatment
por: Clarke, Jennifer, et al.
Publicado: (2013)

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
por: Daei Sorkhabi, Amin, et al.
Publicado: (2022)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019)

Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme
por: Haskins, William E., et al.
Publicado: (2013)

BSCI-19 A LENTIVIRAL CRISPR SCREEN FOR EPIGENETIC MODULATORS OF ANTIGENS TARGETED BY CAR T CELLS IN GLIOBLASTOMA
por: Jordan Walter, T, et al.
Publicado: (2022)

Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience
por: Hasan, Shaakir, et al.
Publicado: (2015)

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
por: Jackson, Christopher, et al.
Publicado: (2011)

Cell-based immunotherapy of glioblastoma multiforme
por: Bryukhovetskiy, Igor
Publicado: (2022)

Adult Brainstem Glioblastoma Multiforme: Long-term Survivor
por: Barnard, Zachary R, et al.
Publicado: (2015)

Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines
por: Demircan, Turan, et al.
Publicado: (2021)

Neurocytological Advances in the Treatment of Glioblastoma Multiforme
por: Fiani, Brian, et al.
Publicado: (2021)

337 Targeting metabolic and epigenetic programs to re-sensitize glioblastoma to chemotherapy
por: Rowland, Emma, et al.
Publicado: (2023)

Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment
por: Mungur, Rajneesh, et al.
Publicado: (2022)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
por: Xu, Xun, et al.
Publicado: (2012)

Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
por: Tan, Sze Kiat, et al.
Publicado: (2018)

A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme
por: de Aquino, Priscila F., et al.
Publicado: (2016)

Subtotal Resection of a Thalamic Glioblastoma Multiforme through Transsylvian Approach
por: Motiei-Langroudi, Rouzbeh, et al.
Publicado: (2017)

Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
por: Gesundheit, Benjamin, et al.
Publicado: (2020)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020)

Epigenetic Targeting of Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects
por: Chowdhury, Selia, et al.
Publicado: (2021)

Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020)

Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation
por: Ciernik, I. Frank, et al.
Publicado: (2020)

Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma
por: Li, Junsheng, et al.
Publicado: (2021)

Trigone ventricular glioblastoma multiforme with trapped temporal horn: A case report
por: Liu, Lei, et al.
Publicado: (2022)

Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme
por: Aisa, Adilai, et al.
Publicado: (2022)

Investigating the impact of headaches on the quality of life of patients with glioblastoma multiforme: a qualitative study
por: Bennett, Samuel Robert, et al.
Publicado: (2016)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme
por: Han, Xudong, et al.
Publicado: (2020)

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
por: Bergmann, Natalie, et al.
Publicado: (2020)

Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis
por: Yang, Ji’an, et al.
Publicado: (2021)

Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI
por: Cai, Xiaomin, et al.
Publicado: (2022)

MRI radiomic features of peritumoral edema may predict the recurrence sites of glioblastoma multiforme
por: Long, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lhah1484fk90iacit1antu5one